Jessie Yan

Haihua Life Group Company was established in 2012, and the group includes Xiamen Hailejing Biochemical Co., Ltd., Haihua Life (Xiamen) Technology Co., Ltd., Peking Pharma group Limited (HK), Halo lifescience (Dubai), Global Pharma solution (Oman), LFR pekin Pharma (Algeria).

The company boasts outstanding R&D capabilities, with a team assembled from top talents. Leveraging interdisciplinary knowledge and rich experience, we conduct in-depth research and innovation in major fields such as antiviral, anti-tumor, cardiovascular, and immunosuppression. Our product types cover chemical raw materials and preparations, biological products, and more.

Haihua Life has an efficient and powerful R&D team and an experienced production team, supported by a cGMP production quality system aligned with international standards. We possess global commercialization capabilities, with markets covering China, the US, Europe, the Middle East, Africa, and other

Haihua Life is committed to building a high-tech pharmaceutical enterprise with international competitiveness that integrates engineering, technology, and product services, and becoming the most trusted partner of global pharmaceutical companies.